Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

J&J’s Caruso Pitches OTC Comeback To Analysts

This article was originally published in The Tan Sheet

Executive Summary

Johnson & Johnson will not “shortchange” its commitment to returning its recalled consumer brands to the marketplace, Chief Financial Officer Dominic Caruso says.
Advertisement

Related Content

J&J Extends Delay In Returning Some OTCs To Market
J&J Extends Delay In Returning Some OTCs To Market
J&J Brand Revival Plan Relies On Marketing, Delivery Innovation
J&J Brand Revival Plan Relies On Marketing, Delivery Innovation
Merck Looks To “Exploit” Switches With Exit From J&J Joint Venture
J&J Directors Find Root Causes But Little Blame For OTC Quality Issues
J&J Consumer Recaptures Growth, Plans To Restore Most OTCs By Mid-2012
J&J Expands Russian OTC Foothold Via J.B. Chemicals Portfolio Acquisition
J&J Expands Russian OTC Foothold Via J.B. Chemicals Portfolio Acquisition
Under Consent Decree, J&J Delays Full Return Of Recalled OTCs Until 2012

Topics

Advertisement
UsernamePublicRestriction

Register

PS105302

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel